Forensic Testing of Narcotic Drugs and Psychotropic Substances: Challenges and Policy Responses

The global surge in drug abuse and trafficking presents multifaceted challenges for forensic laboratories and law enforcement agencies. According to the United Nations Office on Drugs and Crime (UNODC), approximately 296 million individuals used drugs worldwide in 2021, including 13.2 million people who injected drugs, underscoring a growing global health and forensic concern. In India, the Narcotic Drugs and Psychotropic Substances (NDPS) Act serves as the cornerstone for legal proceedings, necessitating robust infrastructure, skilled personnel, and standardized analytical protocols. International bodies such as the UNODC, the Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG), and the World Health Organization have established analytical and procedural frameworks that guide the reliable identification, quantification, and interpretation of controlled substances. Furthermore, national authorities such as the Directorate of Forensic Science Services (DFSS) have emphasized compliance with these standards to ensure scientific credibility and legal defensibility. This article outlines the increasing analytical and administrative burden on forensic laboratories, highlights international guidelines, and emphasizes the urgent need for capacity building, data centralization, and uniform reporting standards. The article advocates for ethical compliance, interagency collaboration, international cooperation, and the implementation of robust quality management systems to enhance the credibility, reliability, and efficiency of NDPS-related forensic analysis.